dc.contributor.author
Rosenthal, Lisa-Maria
dc.contributor.author
Danne, Friederike
dc.contributor.author
de Belsunce, Sophie
dc.contributor.author
Spath, Lisa
dc.contributor.author
Badur, Chiara-Aiyleen
dc.contributor.author
Photiadis, Joachim
dc.contributor.author
Berger, Felix
dc.contributor.author
Schmitt, Katharina
dc.date.accessioned
2025-08-05T11:37:04Z
dc.date.available
2025-08-05T11:37:04Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/48572
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-48296
dc.description.abstract
Objective: Interstage home monitoring (IHM) programs are considered standard of care after Norwood palliation and have led to substantial improvements in clinical outcomes. This study aims to evaluate an application-based remote IHM program for infants with shunt- or duct-dependent pulmonary circulation. The primary goals were to discharge infants from the hospital while minimizing mortality, optimizing somatic growth, and enhancing caregivers' confidence in the clinical management at home.
Methods: Infants with shunt-dependent single ventricle physiology or complex biventricular physiology requiring staged palliation with aortopulmonary shunt were enrolled for the study. Caregivers completed a comprehensive education program on the clinical management of their child at home and were asked to remotely send monitoring data using an application. We analyzed demographic data and clinical outcomes; evaluated patient acceptance and adherence, as well as data entry patterns and metrics; and compared these to a historical control group monitored in a non-remote IHM program and with a propensity score-matched cohort adjusted for baseline characteristics.
Results: We enrolled 30 infants in the remote IHM program between July 2021 and May 2024. The median duration of IHM was 110 days (IQR 75–140). A median of 353 (IQR 351–743) data entries were sent per patient during IHM of which 0.8% (IQR 0.3–1.9) were pathological. Readmissions (63%) and interventions (57%) were common, mainly due to cyanosis and infections. As all infants survived stage II palliation, interstage mortality could be reduced to 0% compared to 10.3% in the historical control group and was significantly lower compared to the propensity score-matched cohort with 14% (P = 0.032).
Conclusion: Application-based remote IHM for infants with duct- or shunt-dependent pulmonary perfusion is feasible, with high acceptance and adherence. The program significantly reduced interstage mortality compared to traditional monitoring methods. Remote patient monitoring (RPM) improves communication between caregivers and healthcare teams, allowing for early intervention and optimized patient outcomes. RPM has the potential to improve outcomes, enhance patient safety, and reduce family burden in this high-risk population.
en
dc.rights.uri
https://creativecommons.org/licenses/by/4.0/
dc.subject
remote patient monitoring
en
dc.subject
interstage monitoring
en
dc.subject
application-based monitoring
en
dc.subject
single ventricle heart disease
en
dc.subject
Norwood palliation
en
dc.subject
shunt-dependent pulmonary perfusion
en
dc.subject
duct-dependent pulmonary perfusion
en
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit
dc.title
Application-based remote interstage home monitoring for infants with shunt- or duct-dependent pulmonary perfusion
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation.articlenumber
1493698
dcterms.bibliographicCitation.doi
10.3389/fcvm.2024.1493698
dcterms.bibliographicCitation.journaltitle
Frontiers in Cardiovascular Medicine
dcterms.bibliographicCitation.originalpublishername
Frontiers Media SA
dcterms.bibliographicCitation.volume
11
refubium.affiliation
Charité - Universitätsmedizin Berlin
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.bibliographicCitation.pmid
39834740
dcterms.isPartOf.eissn
2297-055X